ALOCRIL Drug Patent Profile
✉ Email this page to a colleague
When do Alocril patents expire, and what generic alternatives are available?
Alocril is a drug marketed by Allergan and is included in one NDA.
The generic ingredient in ALOCRIL is nedocromil sodium. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the nedocromil sodium profile page.
Summary for ALOCRIL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 43 |
Patent Applications: | 3,807 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for ALOCRIL |
What excipients (inactive ingredients) are in ALOCRIL? | ALOCRIL excipients list |
DailyMed Link: | ALOCRIL at DailyMed |
Pharmacology for ALOCRIL
Drug Class | Mast Cell Stabilizer |
Physiological Effect | Decreased Histamine Release |
Anatomical Therapeutic Chemical (ATC) Classes for ALOCRIL
US Patents and Regulatory Information for ALOCRIL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Allergan | ALOCRIL | nedocromil sodium | SOLUTION/DROPS;OPHTHALMIC | 021009-001 | Dec 8, 1999 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ALOCRIL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Allergan | ALOCRIL | nedocromil sodium | SOLUTION/DROPS;OPHTHALMIC | 021009-001 | Dec 8, 1999 | ⤷ Try a Trial | ⤷ Try a Trial |
Allergan | ALOCRIL | nedocromil sodium | SOLUTION/DROPS;OPHTHALMIC | 021009-001 | Dec 8, 1999 | ⤷ Try a Trial | ⤷ Try a Trial |
Allergan | ALOCRIL | nedocromil sodium | SOLUTION/DROPS;OPHTHALMIC | 021009-001 | Dec 8, 1999 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ALOCRIL
See the table below for patents covering ALOCRIL around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
New Zealand | 223026 | PHARMACEUTICAL COMPOSITIONS CONTAINING AQUEOUS SOLUTION OF 9-ETHYL-6,9-DIHYDRO-4,6-DIOXO-10-PROPYL-4H-PYRANO (3,2-G)QUINOLINE-2,8-DICARBOXYLIC ACID | ⤷ Try a Trial |
Germany | 3584580 | ⤷ Try a Trial | |
Spain | 469391 | ⤷ Try a Trial | |
Norway | 172542 | ⤷ Try a Trial | |
Japan | 2568233 | ⤷ Try a Trial | |
France | 2609392 | COMPOSITIONS PHARMACEUTIQUES CONTENANT DES PYRANOQUINOLEINES | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |